Cite
HARVARD Citation
Van den Berghe, N. et al. (n.d.). P311 Intensive dried blood spot sampling shows a higher drug exposure throughout the first 24 weeks of therapy in ustekinumab-treated Crohn's disease patients achieving endoscopic remission. Journal of Crohn's and colitis. pp. S338-S339. [Online].